Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Krishna Nalleballe

Concepts (151)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
14
2022
524
2.650
Why?
Fibrinolytic Agents
4
2022
139
1.330
Why?
Thrombolytic Therapy
4
2022
127
1.320
Why?
Pneumonia, Viral
6
2020
184
1.310
Why?
Coronavirus Infections
6
2020
192
1.290
Why?
Tissue Plasminogen Activator
3
2020
124
1.290
Why?
Endovascular Procedures
2
2022
186
0.860
Why?
Pandemics
8
2020
579
0.850
Why?
Cavernous Sinus
1
2022
15
0.840
Why?
Carotid-Cavernous Sinus Fistula
1
2022
13
0.830
Why?
Conflict of Interest
2
2020
24
0.770
Why?
Embolization, Therapeutic
1
2022
98
0.760
Why?
Iodine Compounds
1
2020
7
0.750
Why?
Brain Edema
1
2020
39
0.720
Why?
Mucopolysaccharidosis II
1
2018
1
0.670
Why?
Brain Ischemia
4
2022
169
0.670
Why?
Medicare
1
2020
240
0.670
Why?
Contrast Media
1
2020
221
0.660
Why?
Cardiology
1
2020
105
0.660
Why?
Coronary Angiography
1
2020
411
0.630
Why?
Physicians
1
2020
247
0.580
Why?
Hospitalization
6
2022
705
0.520
Why?
Databases, Factual
3
2020
684
0.450
Why?
Telemedicine
1
2019
449
0.440
Why?
Humans
29
2022
54246
0.410
Why?
Headache
2
2022
78
0.390
Why?
Aged
10
2021
10041
0.370
Why?
Autoimmune Diseases
2
2020
114
0.350
Why?
Time Factors
4
2020
3212
0.350
Why?
Ischemic Attack, Transient
2
2020
60
0.350
Why?
Immunosuppressive Agents
2
2020
248
0.330
Why?
United States
6
2020
5200
0.310
Why?
Female
16
2021
28418
0.290
Why?
Arkansas
4
2019
2094
0.280
Why?
Male
14
2021
27312
0.270
Why?
Emergency Service, Hospital
2
2020
538
0.260
Why?
Middle Aged
11
2021
13070
0.260
Why?
Triage
2
2021
76
0.240
Why?
Tomography, X-Ray Computed
2
2020
1213
0.230
Why?
Thrombectomy
2
2020
68
0.230
Why?
Drug Industry
2
2020
40
0.230
Why?
Neuroimaging
2
2020
88
0.230
Why?
Critical Care
2
2021
234
0.200
Why?
Retrospective Studies
5
2020
6432
0.200
Why?
Sinus Thrombosis, Intracranial
1
2021
20
0.200
Why?
Myasthenia Gravis
1
2021
17
0.200
Why?
Hospitalists
1
2020
14
0.190
Why?
Intracranial Thrombosis
1
2020
22
0.190
Why?
Ageusia
1
2020
7
0.190
Why?
Olfaction Disorders
1
2020
8
0.190
Why?
Neuromuscular Diseases
1
2020
33
0.190
Why?
Health Services Misuse
1
2020
15
0.190
Why?
Osmolar Concentration
1
2020
83
0.190
Why?
Lymphoma, Non-Hodgkin
1
2020
63
0.180
Why?
Health Care Sector
1
2020
17
0.180
Why?
Infarction, Middle Cerebral Artery
1
2020
44
0.180
Why?
Multiple Sclerosis
1
2020
72
0.180
Why?
Neurologic Examination
1
2020
76
0.180
Why?
Time-to-Treatment
1
2020
74
0.180
Why?
Mood Disorders
1
2020
63
0.180
Why?
Patient Transfer
1
2020
103
0.180
Why?
Brain Diseases
1
2020
87
0.180
Why?
Venous Thrombosis
1
2020
102
0.180
Why?
Subarachnoid Hemorrhage
1
2020
65
0.180
Why?
Suicidal Ideation
1
2020
96
0.170
Why?
Young Adult
2
2020
4308
0.170
Why?
Recombinant Fusion Proteins
1
2010
206
0.170
Why?
Fabry Disease
1
2019
9
0.170
Why?
Enzyme Replacement Therapy
1
2019
19
0.170
Why?
Hospitals
1
2020
188
0.170
Why?
Drug-Eluting Stents
1
2020
116
0.170
Why?
Fluorocarbons
1
2019
52
0.170
Why?
Nervous System Diseases
1
2020
97
0.170
Why?
Tomography Scanners, X-Ray Computed
1
2018
14
0.170
Why?
Angiography, Digital Subtraction
1
2018
33
0.170
Why?
Angiogenesis Inhibitors
1
2010
203
0.160
Why?
Seizures
1
2020
208
0.160
Why?
Anxiety
1
2020
278
0.160
Why?
Neuroprotective Agents
1
2019
125
0.160
Why?
Aged, 80 and over
3
2020
3429
0.160
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
132
0.150
Why?
Pain
1
2020
405
0.150
Why?
Meningitis
1
2016
24
0.150
Why?
Referral and Consultation
1
2019
307
0.140
Why?
Diagnosis, Differential
1
2020
1136
0.140
Why?
Myocardial Infarction
1
2020
424
0.140
Why?
Percutaneous Coronary Intervention
1
2020
338
0.130
Why?
Ovarian Neoplasms
1
2010
472
0.130
Why?
Plasma Cells
1
2016
238
0.130
Why?
Antibodies, Monoclonal
1
2010
562
0.130
Why?
Magnetic Resonance Imaging
2
2020
1604
0.130
Why?
Adult
5
2020
14182
0.120
Why?
RNA-Directed DNA Polymerase
1
2002
7
0.110
Why?
Oligodeoxyribonucleotides
1
2002
30
0.110
Why?
DNA, Complementary
1
2002
145
0.110
Why?
Adolescent
2
2020
6885
0.100
Why?
Antineoplastic Agents
1
2010
1300
0.100
Why?
Mycobacterium tuberculosis
1
2002
212
0.100
Why?
Treatment Outcome
4
2022
5604
0.090
Why?
Intubation, Intratracheal
2
2021
130
0.090
Why?
Cohort Studies
2
2022
1543
0.070
Why?
Prevalence
2
2020
1022
0.070
Why?
Intracranial Hemorrhages
1
2022
41
0.050
Why?
Risk Factors
2
2022
3930
0.050
Why?
Cerebral Hemorrhage
1
2022
102
0.050
Why?
Multiple Myeloma
1
2016
3035
0.050
Why?
Cranial Sinuses
1
2021
11
0.050
Why?
Industry
1
2020
19
0.050
Why?
Arthritis, Psoriatic
1
2020
11
0.050
Why?
Spondylitis, Ankylosing
1
2020
11
0.050
Why?
Cranial Nerves
1
2020
14
0.050
Why?
Disease Susceptibility
1
2021
95
0.050
Why?
Endocrine System Diseases
1
2010
9
0.050
Why?
Colitis, Ulcerative
1
2020
52
0.050
Why?
Receptors, Vascular Endothelial Growth Factor
1
2010
25
0.050
Why?
Mortality
1
2020
102
0.050
Why?
Registries
1
2022
553
0.040
Why?
Maximum Tolerated Dose
1
2019
37
0.040
Why?
Crohn Disease
1
2020
96
0.040
Why?
Arthritis, Rheumatoid
1
2020
130
0.040
Why?
Tertiary Care Centers
1
2019
83
0.040
Why?
Administration, Oral
1
2020
459
0.040
Why?
alpha-Galactosidase
1
2019
9
0.040
Why?
Disease Outbreaks
1
2020
124
0.040
Why?
Administration, Intravenous
1
2019
75
0.040
Why?
Hemorrhage
1
2020
208
0.040
Why?
Disability Evaluation
1
2019
103
0.040
Why?
Gastrointestinal Diseases
1
2010
126
0.040
Why?
Electronic Health Records
1
2021
205
0.040
Why?
Drug Administration Schedule
1
2019
401
0.040
Why?
Skin Diseases
1
2010
141
0.040
Why?
Recovery of Function
1
2019
222
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2010
240
0.040
Why?
Comorbidity
1
2019
663
0.040
Why?
Patient Readmission
1
2019
242
0.040
Why?
Double-Blind Method
1
2019
742
0.040
Why?
Prognosis
1
2022
2118
0.040
Why?
Fatal Outcome
1
2016
225
0.030
Why?
Follow-Up Studies
1
2020
2387
0.030
Why?
Risk Assessment
1
2019
1361
0.030
Why?
Cardiovascular Diseases
1
2010
475
0.030
Why?
Cross-Sectional Studies
1
2019
1679
0.030
Why?
Prospective Studies
1
2020
2604
0.030
Why?
DNA Primers
1
2002
225
0.030
Why?
Infant
1
2020
3817
0.030
Why?
Child, Preschool
1
2020
4146
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2002
474
0.020
Why?
Transcription, Genetic
1
2002
418
0.020
Why?
Gene Expression Regulation, Bacterial
1
2002
244
0.020
Why?
RNA, Messenger
1
2002
1202
0.020
Why?
Child
1
2020
7337
0.020
Why?
Nalleballe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description